Gagnon Robert E. — SEC insider filings
SEC reporting owner CIK 1504983. 40 insider filings on record with FilingPulse; latest filed 2026-10-27.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-08-13 to 2026-10-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 34 legs across 26 filings — 145,059 shares, $578,818 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 28,000 shares @ $4.54 ($127,212) in Opus Genetics, Inc., filed 2026-09-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Verastem, Inc. (VSTM) | Director | 28 | — | 30 legs · 87,434 sh · $338,356 | 13 |
| Opus Genetics, Inc. (IRD) | Chief Financial Officer | 6 | — | 4 legs · 57,625 sh · $240,462 | 3 |
| Bone Biologics Corp (BBLG) | Director | 4 | — | — | 5 |
| HARVARD BIOSCIENCE INC (HBIO) | Director | 2 | — | — | 2 |
Insider filings — Gagnon Robert E.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 14,000 @ $3.55 | EDGAR |
| 2026-09-30 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 113,896 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 28,000 @ $4.54 | EDGAR |
| 2026-07-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,783 @ $2.95 | EDGAR |
| 2026-06-11 | 4 | HARVARD BIOSCIENCE INC (HBIO) | Grant/award (A): 16,556 @ $0 | EDGAR |
| 2026-04-27 | 4 | Opus Genetics, Inc. (IRD) | Sale (S): 7,842 @ $5.18 | EDGAR |
| 2026-01-26 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2025-12-18 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $9.14 | EDGAR |
| 2025-09-18 | 4 | Verastem, Inc. (VSTM) | Sale (S): 281 @ $9.99 | EDGAR |
| 2025-09-11 | 4 | Opus Genetics, Inc. (IRD) | Grant/award (A): 200,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-07-18 | 4 | HARVARD BIOSCIENCE INC (HBIO) | Grant/award (A): 110,000 @ $0 | EDGAR |
| 2025-06-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 284 @ $5.65 | EDGAR |
| 2025-06-06 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 62,894 (derivative) @ $0 | EDGAR |
| 2025-05-27 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 8,333 @ $0 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | Verastem, Inc. (VSTM) | Sale (S): 284 @ $6.95 | EDGAR |
| 2024-12-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 285 @ $4.54 · Sale (S): 130 @ $4.37 | EDGAR |
| 2024-09-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 131 @ $2.79 | EDGAR |
| 2024-09-19 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 30,713 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | Verastem, Inc. (VSTM) | Sale (S): 287 @ $2.80 | EDGAR |
| 2024-06-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $3.49 · Grant/award (A): 8,333 @ $0 · Sale (S): 131 @ $3.21 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-03-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $10.71 · Sale (S): 130 @ $10.38 | EDGAR |
| 2024-02-07 | 4 | Verastem, Inc. (VSTM) | Sale (S): 9,204 @ $13.70 | EDGAR |
| 2024-01-17 | 4 | Verastem, Inc. (VSTM) | Sale (S): 9,204 @ $10.95 | EDGAR |
| 2024-01-10 | 4 | Bone Biologics Corp (BBLG) | Grant/award (A): 9 (derivative) @ $0 · Grant/award (A): 8.01 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 284 @ $7.64 · Sale (S): 130 @ $7.73 | EDGAR |
| 2023-09-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 278 @ $9.91 · Sale (S): 130 @ $9.84 | EDGAR |
| 2023-06-21 | 4 | Verastem, Inc. (VSTM) | Sale (S): 283 @ $9.92 · Sale (S): 130 @ $10.30 | EDGAR |
| 2023-05-16 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 3,654 @ $0.40 · Sale (S): 1,664 @ $0.43 | EDGAR |
| 2022-12-20 | 4 | Verastem, Inc. (VSTM) | Sale (S): 12,408 @ $0.40 · Sale (S): 1,429 @ $0.37 | EDGAR |
| 2022-12-15 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 153,938 (derivative) @ $0 | EDGAR |
| 2022-09-21 | 4 | Verastem, Inc. (VSTM) | Sale (S): 1,348 @ $1.13 | EDGAR |
| 2022-06-22 | 4 | Verastem, Inc. (VSTM) | Sale (S): 1,351 @ $1.14 | EDGAR |
| 2022-05-17 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 50,000 @ $0 · Sale (S): 16,627 @ $1.03 | EDGAR |
| 2022-03-23 | 4 | Verastem, Inc. (VSTM) | Sale (S): 1,409 @ $1.27 | EDGAR |
| 2022-01-05 | 4 | Verastem, Inc. (VSTM) | Sale (S): 19,612 @ $2.05 | EDGAR |
| 2021-12-22 | 4 | Verastem, Inc. (VSTM) | Sale (S): 5,497 @ $2.27 | EDGAR |
| 2021-12-17 | 4 | Verastem, Inc. (VSTM) | Tax withholding (F): 45,329 @ $2.87 · Grant/award (A): 148,500 @ $0 · Grant/award (A): 301,500 (derivative) @ $0 | EDGAR |
| 2020-12-22 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 67,925 @ $0 · Grant/award (A): 203,776 (derivative) @ $0 | EDGAR |
| 2020-08-13 | 4 | Verastem, Inc. (VSTM) | Grant/award (A): 290,210 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1504983 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs